Activated leukocyte cell adhesion molecule (ALCAM) and annexin II are involved in the metastatic progression of tumor cells after chemotherapy with Adriamycin
- 1 January 2000
- journal article
- research article
- Published by Springer Nature in Clinical & Experimental Metastasis
- Vol. 18 (1) , 45-50
- https://doi.org/10.1023/a:1026507713080
Abstract
Metastasis frequently occurs during and/or after chemotherapy resulting in failure. This suggests that inadequate chemotherapy promotes the emergence of more malignant tumor cells with metastatic...Keywords
This publication has 28 references indexed in Scilit:
- The plasminogen activator system in pancreas cancer: role of t-PA in the invasive potential in vitroOncogene, 1998
- CD6—ligand interactions: a paradigm for SRCR domain function?Immunology Today, 1997
- Characterization of mouse ALCAM (CD166): the CD6‐binding domain is conserved in different homologs and mediates cross‐species bindingEuropean Journal of Immunology, 1997
- Annexin II Is a Novel Player in Insulin Signal TransductionJournal of Biological Chemistry, 1996
- Expression of annexins on the surfaces of non-metastatic and metastatic human and rodent tumor cellsClinical & Experimental Metastasis, 1993
- Regression mechanisms of mouse fibrosarcoma cells after in vitro exposure to quercetin: Diminution of tumorigenicity with a corresponding decrease in the production of prostaglandin E2Cancer Immunology, Immunotherapy, 1990
- Expression of annexins as a function of cellular growth state.The Journal of cell biology, 1990
- Gene products which play a role in cancer invasion and metastasisBreast Cancer Research and Treatment, 1988
- FACILITATION OF TUMOUR PROGRESSION BY CANCER THERAPYThe Lancet, 1982
- The pathogenesis of cancer metastasisNature, 1980